True aneurysm formation in arterialized autologous veins is an unusual complication. We studied a patient with 2 aneurysms occurring in the mid and distal portion of an in situ femoropopliteal bypass. The first aneurysm led to graft occlusion 4 years after the primary intervention, requiring replacement of the ectatic graft segment. The graft was still patent when the patient was examined 7 years after the primary intervention and 3 years after the first aneurysm. In the mid portion of the graft, a true aneurysm measuring 5 by 8 cm had developed. The aneurysm was replaced by a reversed segment of the contralateral greater saphenous vein. Recovery was uneventful. Advanced atherosclerotic changes with extensive intimal fibroplasia, subendothelial cholesterol deposits, and ulcerations were revealed by means of histopathology of the aneurysm wall. Atherosclerosis is considered to be the main cause of aneurysm formation in vein grafts, but a review of the literature suggests the additional etiopathogenic factors should be further investigated. (J Vasc Surg 1998;28:944-8.)
True aneurysm formation within arterialized saphenous vein grafts is an unusual complication of bypass graft surgery. Davidson first described this entity in 1972. 1 In 1973, Szilagyi 2 reported on the biologic fate of saphenous vein grafts in 260 patients. Atherosclerotic degeneration was found in a third of the patients, but graft aneurysms were found in only 10 patients. Atherosclerosis in the graft was associated with hyperlipidemia and arterial hypertension. Cardiovascular risk factors did not correlate with graft aneurysms. [3] [4] [5] [6] The cause of vein graft aneurysms is still unclear; atherosclerosis is thought to be one of the main factors in their development. 7 We studied a patient with 2 true aneurysms in the mid and distal portion of an in situ femoropopliteal bypass graft, which had been implanted 7 years earlier for the treatment of a thrombosed popliteal artery aneurysm. Pertinent literature is reviewed and particular attention is given to the etiopathogenic factors involved in this disorder and its clinical consequences.
CASE REPORT
Seven years ago, a 55-year-old man came to our institution with an acute thrombosed right popliteal aneurysm. An in situ saphenous vein graft was implanted. His past medical history was remarkable for longstanding arterial hypertension and heavy cigarette smoking. The patient had no diabetes mellitus, and his cholesterol and triglyceride levels were normal. Three years after the first intervention, he had a sudden onset of resting right leg pain, and graft thrombosis was revealed by means of angiography. The patient underwent thrombectomy and thrombolysis, which resulted in complete recanalization. In the graft, a true aneurysm 4 cm proximal of the anastomosis to the popliteal artery had developed. The aneurysmatic segment was replaced by a reversed saphenous vein from the contralateral side, requiring a new anastomosis to the tibioperoneal trunk. Recovery was uneventful, but the patient continued smoking. Four years later, the patient noted a growing pulsatile mass in his right thigh. Within 4 weeks, the mass expanded rapidly, causing extreme discomfort because of tension on the overlying skin. Dilatation of the in situ portion of the graft and an aneurysm measuring 5 cm in transverse diameter and extending over 8 cm at the level of the midthigh were disclosed by means of color duplex Doppler ultrasound scan and magnetic resonance (MR) angiography (Fig 1) . The ectatic portion of the graft was replaced by a reversed segment of greater saphenous vein (Fig 2) . Recovery was uneventful, and the patient was included in a follow-up program with regular graft mapping by means of color duplex Doppler ultrasound scan every 6 months. After 1 year of follow-up, the graft remained patent and had no signs of dilatation. By means of histopathologic examination of the explanted aneurysm, it was revealed that the structural architecture of the vessel wall was obliterated by invading atherosclerotic plaques (Fig 3) . Extensive intimal fibroplasia was noted, and the thickened intima was altered by hemorrhage and cholesterol deposits with ulceration and focal thrombi. A specimen of excised aneurysmal vein bypass graft was sent for microbiological examination. Cultures were negative for gram-positive, gram-negative, and anaerobic organisms and for fungi and mycobacteria.
DISCUSSION
The autologous saphenous vein represents the conduit of choice for revascularization of the lower extremity. Histopathologic changes in the vein grafts have been well known since the initial development of this technique. Endothelial disruption and subendothelial transformation, such as medial necrosis, loss of elastic elements, and fibrous proliferation, are the main findings. 8 Long-term follow-up studies lasting up to 10 years showed severe atherosclerotic degeneration of the grafts, frequently associated with hyperlipidemia and arterial hypertension. [3] [4] These changes were found in one third of the explanted veins used for femoropopliteal reconstruction. 2 In saphenous vein grafts used for coronary artery bypass grafting, marked atherosclerotic changes were observed in more than 50% of conduits. 9 Manipulation of the vein during harvest may cause loss of endothelial integrity, with subsequent increase in cellular proliferation and lipid infiltration. 10 It was postulated that the use of in situ grafting could reduce atherosclerotic degeneration of the vein, 11 but follow-up studies showed that long-term patency rates are similar for both reversed and in situ saphenous grafts. [12] [13] In contrast to denatured venous homografts, 14 true aneurysm formation in arterialized autologous veins is an unusual occurrence. Szilagyi 2 found 10 venous aneurysms in 377 operated legs, but none required surgical reintervention. The world literature on infrainguinal nonanastomotic aneurysms in vein grafts is summarized in Table I . Clinical manifestation is mostly characterized by a pulsatile mass, which may lead to skin ulceration, acute rupture, graft thrombosis, or distal embolization. According to the literature, the mean time from graft implantation to clinical manifestation of the aneurysm is 7 years, but graft dilatation was observed as early as 2 years postoperatively. 15 DeWeese 16 reported aneurysm formation 1 year after graft implantation with a postoperative recurrence 5 months later, but infection rather than atherosclerosis was suspected to be the cause of early aneurysms. In our case, the first aneurysm developed 3 years after in situ grafting, and it was corrected with a venous interposition. The same procedure was used 4 years later when a second aneurysm formed in the original portion of the graft. A short-segment of the anterior tibial artery was shown by means of MR angiography to be the only runoff vessel in the calf. This is a common occurrence in patients with long-standing femoro-popliteal aneurysm, because this represents a source of recurrent emboli leading to chronic occlusion of calf vessels. The choice of a vein rather than of a prosthetic conduit to repair graft aneurysm in this young patient was dictated (1) by the higher long-term patency rate of autologous material for below-knee reconstruction, especially if there are poor runoff vessels; (2) because it was not possible at surgery to exclude a low-grade mycotic aneurysm, and therefore, the implantation of an autologous graft was preferred; (3) by the positive experience with the distal part of the graft, which had been replaced 4 years earlier with a reversed segment of the left greater saphenous vein and was still patent and not dilatated.
The etiology of venous graft aneurysms remains unclear; however, some factors have been proposed as at least partly responsible for this long-term complication after bypass graft surgery. In a number of graft aneurysms reported (Table I) , the bypass graft has been performed to repair a popliteal artery aneurysm, and concomitant abdominal aortic aneurysm was a frequent finding. This suggests a generalized propensity of aneurysms to develop both in arteries and arterialized veins in some patients. Advanced atherosclerotic changes with extensive intimal fibroplasia, subendothelial cholesterol deposits, and ulcerations 
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were disclosed by means of histopathologic examination of the aneurysm. These micromorphologic changes cause weakening of the vascular wall, especially because of penetrating atherosclerotic plaques with subsequent mural destruction, and, therefore, atherosclerosis is considered to be the main cause for aneurysm formation in arterialized vein grafts. 7 Atherosclerosis affects approximately 30% to 50% of arterialized veins, but true graft aneurysms represent an unusual complication. Therefore, additional etiologic factors leading to graft aneurysm should be considered.
A poststenotic dilatation has been proved to be responsible for the development of aneurysms (hemodynamic origin). A poststenotic dilatation becomes a true aneurysm when the diameter criterion is met and the ectasia becomes permanent and fixed. Classic examples are cervical rib and impingement on peripheral arteries (eg, popliteal entrapment). Similarly, a stenotic segment in the vein graft (eg, valvular stenosis or postphlebitic) or a graft impingement could produce a poststenotic dilatation with subsequent development of an aneurysm. Vessel dilatation causes boundary layer separation along the intimal surface, and hemodynamic forces stimulate subintimal proliferative changes resulting in plaque formation. 17 This is supported by the evidence that arteriosclerotic changes also occur in poststenotic aneurysms.
Graft aneurysms can develop from a low-grade graft infection (mycotic aneurysm). Cultures of an excised specimen of the aneurysm were negative, but infections with slowly growing microorganisms, such as Staphylococcus epidermidis, are difficult to detect. In prosthetic graft infections, mechanical disruption of the bacteria from the graft surface, either by means of tissue grinding or ultrasonic disruption, and culture in broth media increase the identification of bacteria compared with routine culture methods. 18 The efficacy of this method, however, for venous grafts was not proved.
There is evidence of excessive tobacco consumption in most patients with graft aneurysms. Tobacco is a risk factor for accelerated atherosclerosis, but the role of nicotine as an independent predictor of abdominal aortic aneurysm is debated because nicotine plays an active role in the development of vascular disease by inducing neutrophils to release elastase activity. 19 A similar mechanism on vein grafts has not been investigated yet.
The management of vein graft aneurysm is subject to the same criteria that apply to other aneurysms, and surgical repair is indicated. According to the literature reviewed and in our personal observation, graft dilatation occurs in several months and is followed by a rapid increase in size within a few weeks, leading to pain, skin tension, and possible rupture. Therefore, graft aneurysms, once diagnosed, should be repaired as soon as possible. In the presence of a diffuse dilatation, the entire graft should be replaced. If there is evidence of an isolated aneurysm, the graft can be preserved and the aneurysm replaced with autologous or prosthetic interposition. In these cases, it is mandatory to follow up the graft throughout the patient's life.
